Current Pharmaceutical Design
Title:Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy
Volume: 23 Issue: 35
Author(s): Ahmed O. Elzoghby *
Affiliation:
- Director of Cancer Nanotechnology Research Laboratory (CNRL) Department of Industrial Pharmacy Faculty of Pharmacy Alexandria University, Alexandria 21521,Egypt
Export Options
About this article
Cite this article as:
Elzoghby O. Ahmed*, Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy, Current Pharmaceutical Design 2017; 23 (35) . https://dx.doi.org/10.2174/1381612823999171106125801
DOI https://dx.doi.org/10.2174/1381612823999171106125801 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
33
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preface [Hot Topic: Cellular Targets for Anti-Cancer Therapy (Guest Editor: Alexander A. Shtil)]
Current Drug Targets Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Dual Inhibitors of Src and Abl Tyrosine Kinases
Drug Design Reviews - Online (Discontinued) Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Reviews on Recent Clinical Trials Emerging Anabolic Treatments in Osteoporosis
Current Drug Safety Biological and Toxicological Evaluation of N-(4methyl-phenyl)-4-methylphthalimide on Bone Cancer in Mice
Anti-Cancer Agents in Medicinal Chemistry Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids
Current Medicinal Chemistry Protein Bioinformatics Applied to Virology
Current Protein & Peptide Science Long-Term Benzodiazepine Use and Mortality: Are we Doing the Right Studies?
Current Drug Safety Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Current Pharmaceutical Design Editorial (Hot Topic: The Bioenergetics of Cancer, the Warburg Hypothesis and the Mitochondrial Function)
Current Pharmaceutical Biotechnology Brachial Plexopathy as a Complication of Radiotherapy: A Systematic Review
Current Cancer Therapy Reviews Fragment Based Drug Design: From Experimental to Computational Approaches
Current Medicinal Chemistry Role of Interleukin-17F in Asthma
Inflammation & Allergy - Drug Targets (Discontinued) Analyzing LC/MS Metabolic Profiling Data in the Context of Existing Metabolic Networks
Current Metabolomics S100A1: Structure, Function, and Therapeutic Potential
Current Chemical Biology Omega-3 Polyunsaturated Fatty Acids Enhance Cisplatin Efficacy in Gastric Cancer Cells by Inducing Apoptosis via ADORA1
Anti-Cancer Agents in Medicinal Chemistry An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds pH-Gradient Incorporation of 9-Nitrocamptothecin in PEGylated Liposomes: Formulation Properties and Efficacy <i>In Vitro</i> and <i>In Vivo</i>
Pharmaceutical Nanotechnology